## 

## 



|Contents|||Page|
|---|---|---|---|
|Foreword<br>from the Chair|and Chief|Executive||
|Report of the Trustees||||
|Independent<br>Auditor's<br>Report|||15|
|Consolidated<br>Statement|of Financial|Activities|19|
|Balance Sheets|||20|
|Statements<br>of Cash Flows|||21|
|Notes to the Financial Statements|||22|





## 

## 



## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 



## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

|Charity Number:|Charity Number:|509294|
|---|---|---|
|Company|Number:|01451533|
|Registered|Office:|185Tadcaster Road, York, YO241GL|



## 

|Our advisors|||||||
|---|---|---|---|---|---|---|
|Auditor|Azets Audit Services Ltd|||Triune Court, Monks Cross Drive,|||
|||||York, YO32 9GZ|||
|Bankers|National|Westminster||1 Market Street, York, YO1|8SR||
||Bank||||||
|Solicitors|Hague|8, Dixon||Bank House,<br>1 The Square,|Stamford|Bridge,|
|||||York, YO41 1AG|||
||Lupton|Fawcett||Stamford<br>House, Piccadilly,|York, YO1 9PP||
|Investment|Sarasin|8, Partners|LLP|Juxon House, 100St Paul's|Churchyard,||
|Managers||||London,<br>EC4M 8BU|||
||Ruffer LLP|||80Victoria Street, London,|SW1E5JL||
||CCLA|||Senator House, 85Queen|Victoria Street,||
|||||London,<br>EC4V 4ET|||





## 

## 

|Trustees|and|officers serving|during the year and since the|during the year and since the|year|end were|as fol|
|---|---|---|---|---|---|---|---|
|Trustees|and|directors:|David Dickson (Chair)|||||
||||Sandra Falcus|||||
||||Prof Kate Flemming|||||
||||Khushbu<br>Goulden|||||
||||Juliette Healey|||||
||||Prof Mike Holmes|||||
||||Eamonn<br>Keogh|||||
||||Jacqueline<br>Myers|||||
||||Dr Lavinia<br>Norton|||||
||||Tony Taylor|||||
||||Melanic Kay (appointed<br>October 2022)<br>Kate O' Connell (appointed<br>November||||2022)|
||||Lorna Allan (appointed||June|2023)||
||||Dr Dan Cottingham|(resigned||June 2022)||



|Company Secretary:|Company Secretary:||David Jones|||||
|---|---|---|---|---|---|---|---|
|Senior Management||Team:|Emma Johnson|(Chief Executive)||||
||||Ingrid Jenner|(Director|of People)|||
||||David Jones|(Director|of Finance|8,Corporate||
|||||Services;|appointed|September|2022)|
||||Dr Bill Hulme|(Medical|Director)|||
||||Dawn Clements|(Director|of Income|Generation;||
|||||resigned|July 2023)|||
||||Jenny Brandom|(Director|of Clinical|Services; resigned||
|||||February|2023)|||
||||Anne-Marie<br>Roberts|(Director|of Clinical|Services;||
|||||appointed|March 2023)|||
|Key management|personnel:||St.Leonard's<br>Hospice Enterprises<br>Limited|||||
|Directors:|||Juliette Healey|(Chair)||||
||||David Dickson|||||
||||Mark Shepherd|(resigned October 2022)||||
||||Tony Taylor|(appointed|October|2022)||
|Company Secretary:|||David Jones|||||





## 

## 

## 

## 



## 

## 



## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 



## 

|||||Unrestricted|Restricted|Total Funds|Total<br>Funds|
|---|---|---|---|---|---|---|---|
|||||Funds|Funds|2023|2022|
||||Notes|Ek|Ek|Rk|Ek|
|Income from:||||||||
|Donations and legacies||||2,668|217|2,885|5,153|
|Income from charitable<br>activities:||||||||
|Grants and contract income||||1,769|383|2,152|2,475|
|Income from other trading|activities:|||||||
|Shops||||2,477||2,477|2,128|
|Lottery||||398||398|387|
|Fundraising<br>and other activities||||293||293|394|
|Investment<br>Income||||391||391|407|
|Total income||||7,996|600|8,596|10,944|
|Expenditure<br>on:||||||||
|Costs ofraising funds:||||||||
|Donations and legacies||||781||781|592|
|Shops||||1,914||1,914|1,696|
|Lottery||||196||196|192|
|Fundraising<br>and other activities||||158||158|151|
|Investment<br>Management|Costs|||80||80|81|
|Expenditure<br>on charitable|activities:|||||||
|In-patient<br>Care||||3,962|193|4,155|3,771|
|HospiceHome||||530|681|1,211|1,134|
|Bereavement<br>and Family Support||||195||195|252|
|Total expenditure||||7,816|874|8,690|7,869|
|Net income/<br>(expenditure)<br>recognised<br>gains/ (losses)|before other|||180|(274)|(94)|3,075|
|Realised and unrealised<br>gains/<br>investments||(losses) on||(551)||(551)|472|
|Net income/<br>(expenditure)<br>funds|and|net movement|in|(371)|(274)|(645)|3,547|
|Total funds brought<br>forward||||24,010|1,118|25,128|21,581|
|Total funds carried forward|||23|23,639|844|24,483|25,128|





## 

|alance Sh|eets as a|t 3|1 March|2023|||||
|---|---|---|---|---|---|---|---|---|
||||||Charity||Group||
|||||Notes|2023|2022|2023|2022|
|||||||Rk||Rk|
|Fixed assets|||||||||
|Tangible assets||||17|4,484|4,624|4,484|4,624|
|Investments||||18|17,008|14,909|17,008|14,909|
|Investment|properties|||18|105|105|105|105|
|Total fixed assets|||||21,597|19,638|21,597|19,638|
|Current assets|||||||||
|Stock||||19|16||16|17|
|Debtors||||20|2,576|3,339|2,543|3,286|
|Cash at bank and in||hand|||754|2,570|803|2,621|
|Total current|assets||||3,346|5,909|3,362|5,924|
|Liabilities|||||||||
|Creditors<br>falling due <br>year||within one|||(475)|(432)|(476)|(434)|
|Net current|assets||||2,871|5,477|2,886|5,490|
|Net assets||||23|24,468|25,115|24,483|25,128|
|The funds ofthe charity|||||||||
|Unrestricted|Funds:||||||||
|Unrestricted|general|funds|||10,140|10,373|10,133|10,369|
|Unrestricted|designated||funds||13,484|13,624|13,484|13,624|
|Non-charitable<br>trading|||funds||||22|17|
||||||23,624|23,997|23,639|24,010|
|Restricted income funds||||10|844|1,118|844|1,118|
|Total charity|funds|||23|24,468|25,115|24,483|25,128|





## 

|onsolidated<br>Statement<br>ofCash Flows fo|r the year|ending<br>31|March 2023||
|---|---|---|---|---|
||||2023|2022|
|||Notes|Rk|Rk|
|Net cash provided<br>by operating<br>activities||28|634|1,557|
|Cash flows from investing<br>activities:|||||
|Dividends,<br>interest and rent from investments|||315|331|
|Purchase<br>of property,<br>plant and equipment|||(56)|(46)|
|Proceeds from the sale of property,<br>plant and<br>equipment|||17||
|Payments<br>to acquire investments|||(2,728)|(501)|
|Proceeds from the disposal of investments||||500|
|Net cash (used in)/ provided<br>by financing|activities||(2,452)|284|
|Change<br>in cash and cash equivalents<br>in the year|||(1,818)|1,841|
|Cash and cash equivalents<br>at the start of the year|||2,621|780|
|Total cash and cash equivalents<br>at the end <br>year|ofthe||803|2,621|
|Analysis<br>ofcash and cash equivalents|||||
|Cash at bank and in hand|||803|2,621|
||||803|2,621|





## 

## 



## 



## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

|e summary|financial<br>per|formance<br>of the|charity alone is:||
|---|---|---|---|---|
||||2023|2022|
||||Rk|Rk|
|Income|||8,532|10,880|
|Gift Aid from subsidiary|||24|30|
|company|||||
||||8,556|10,910|
|Expenditure|||(8,652)|(7,835)|
|Net income/expenditure|||(96)|3,075|
|Investment|gains||(551)|472|
|Total funds|brought<br>forward||25,115|21,568|
|Total funds carried forward|||24,468|25,115|
|Represented|by:||||
|Unrestricted|income funds||10,140|10,373|
|Unrestricted|designated|funds|13,484|13,624|
|Restricted income funds|||844|1,118|
||||24,468|25,115|



## 

## 

|Income from donations<br>and|legacies||
|---|---|---|
||2023|2022|
||Kk|Kk|
|Donations|787|2,015|
|Legacies|2,098|3,138|
||2,885|5,153|





## 

## 

## 

||||2023|2022|
|---|---|---|---|---|
||||Kk|Kk|
|Grants and contract income||from|||
|Integrated<br>Care Boards:|||||
|Inpatient<br>and day services|||1,567|1,511|
|HospiceHome|||340|340|
||||1,907|1,851|
|Other funding:|||||
|NHS Pension contributions|paid directly by NHS England||114|97|
|COVID-19 grant paid by NHS||England||458|
|Coronavirus<br>Job Retention|Scheme|||17|
|Carer Support Service|||63||
|Pharmacy<br>Services|||26||
|Project Echo|||42|52|
|Total income from charitable||activities|2,152|2,475|



## 

||||||2023|2022|
|---|---|---|---|---|---|---|
||||||Rk|Rk|
|Income from the sale||of donated||goods|2,414|2,029|
|Income from the sale||of bought||in goods|63|64|
|Retail grant (through||trading|subsidiary)|||35|
|Total income from shops|||||2,477|2,128|
|Costs of buying|in goods||||(34)|(30)|
|Staff costs|||||(1,059)|(977)|
|Other costs|||||(821)|(689)|
|Total expenditure|on|shops|||(1,914)|(1,696)|
|Net profit arising|from|shops|||563|432|





## 

|The summa|ry<br>financial<br>performance|of t|he subsidiary<br>a|lone is:||
|---|---|---|---|---|---|
|||||2023|2022|
|||||Rk|Rk|
|Trading|Income|||63|64|
|Retail grant||||||
|Cost ofsales and administration||costs||(39)|(34)|
|Net profit||||24|30|
|Amount|gift aided to the charity|||(24)|(30)|
|Retained|in subsidiary|||||
|The assets|and liabilities of the subsidiary||were:|||
|||||2023|2022|
|||||Rk|Rk|
|Current|assets|||60|69|
|Current|liabilities|||(27)|(36)|
|Capital|Loan|||(20)|(20)|
|Total net assets||||13|13|
|Aggrega|te<br>share capital and reserves|||13|13|



||2023|2022|
|---|---|---|
||Rk|Rk|
|Income from lottery sales|398|387|
|Prizes|(37)|(37)|
|Other lottery costs|(159)|(155)|
||(196)|(192)|
|Total lottery profits|202|195|





## 

||||2023|2022|
|---|---|---|---|---|
||||Kk|Kk|
|Fundraising<br>events and activities|||223|332|
|Provision of placements/training|||21|10|
|courses|||||
|Room hire|||3|3|
|Catering<br>for staff and|visitors||15|10|
|Industrial<br>injury claims for treating<br>patients<br>with mesothelioma||||29|
|Generating<br>electricity|||4||
|Sponsorship<br>income|||19||
|Miscellaneous<br>income|||8||
|Total income from fundraising||activities|293|394|
|Cost of fundraising<br>events and activities|||(158)|(151)|
|Surplus on fundraising|events and||||
|activities|||||



## 

|e charity received inv|estment<br>income from|the following so|urces du|
|---|---|---|---|
|||2023|2022|
|||Rk|Rk|
|Dividends||339|399|
|Rents from investment|properties|6|7|
|Interest on cash deposits||46|1|
|||391|407|





## 

## 

|Restricted<br>Funds|||Movement|in Funds||
|---|---|---|---|---|---|
|Year ended 31 March 2023||01-Apr|||31-Mar|
|||2022|Income|Expenditure|2023|
||||Kk|Kk|Kk|
|Hospice@Home service||977|374|(666)|685|
|Personalised<br>Care|Project|||(26)|37|
|Hospice@Home vehicle||40||(15)|25|
|Workforce development|||3|||
|Project Echo|||43|(43)||
|ACP Funding||||||
|Equipment<br>Funds|||2|(1)|12|
|Carer Support Service|||63|(10)|53|
|Pharmacy<br>Services|||26|(26)||
|Drugs 8,oxygen|||80|(80)||
|Homelessness<br>Project.|||3|(2)|9|
|Sundry other funds|||6|(5)|10|
|||1,118|600|(874)|844|
|Restricted<br>Funds|||Movement|in Funds||
|Year ended 31 March 2022||01-Apr|||31-Mar|
|||2021|Income<br>Expenditure||2022|
|||||Rk||
|HospiceHome<br>service|||1,362|(385)|977|
|Personalised<br>Care|Project||63||63|
|HospiceHome<br>vehicle|||40||40|
|Workforce development||||||
|Project Echo|||52|(52)||
|ACP Funding||||||
|Equipment<br>Funds||||||
|Service extension/|Covid Co-ordinator|72||(72)||
|NHS England<br>COVID-19 grant|||475|(475)||
|Drugs 8,oxygen|||78|(78)||
|Homelessness<br>Project|||38|(39)||
|Sundry other funds|||5|(4)||
|||110|2,113|(1,105)|1,118|





## 

|nd overhea|d<br>costs of|this project,|this project,|which reached|a conclusio|n<br>in 2023|.|.||
|---|---|---|---|---|---|---|---|---|---|
|Year ended|31 March|2023||||Movement|in Funds|||
|||||01-Apr 2022|Income|Expenditure||Designation|31-Mar 2023|
|||||Kk|Kk||Kk|Kk|Kk|
|Unrestricted|Funds|||10,386|7,996|(8,227)|||10,155|
|Designated|Funds|||||||||
|Fixed Assets Fund||||4,624|||(140)||4,484|
|Building|redevelopment||fund|7,000|||||7,000|
|Retail development||fund||1,500|||||1,500|
|Digital transformation|||fund|500|||||500|
|||||24,010|7,996|(8,367)|||23,639|



|rior year ar|e restated|as below to|as below to|align with the ne|w accounti|ng<br>treatm|ent:|ent:||
|---|---|---|---|---|---|---|---|---|---|
|Year ended|31 March|2022||||Movement|in Funds|||
|||||01-Apr 2021|Income|Expenditure||Designation|31-Mar 2022|
|||||Rk|Rk||Rk|Rk|Rk|
|Unrestricted|Funds|||21,471|9,303|(6,764)||(13,624)|10,386|
|Designated|Funds|||||||||
|Fixed Assets Fund||||||||4,624|4,624|
|Building|redevelopment||fund|||||7,000|7,000|
|Retail development||fund||||||1,500|1,500|
|Digital transformation|||fund|||||500|500|
|||||21,471|9,303|(6,764)|||24,010|





## 

## 

|1.<br>Analysis<br>o|1.<br>Analysis<br>o|f expenditu|re<br>including|governance|and supp|ort costs||
|---|---|---|---|---|---|---|---|
|Forthe year||ended 31|March|Direct|Support|Governance|Total|
|||2023||Costs|Costs|Costs|2023|
|||||Kk|Kk|Kk|Kk|
|Costs ofraising||funds:||||||
|Donations|and|legacies||610|170|1|781|
|Shops||||1,502|409|3|1,914|
|Lottery||||196|||196|
|Fundraising|and other activities|||124|34||158|
|Investment|management||costs|80|||80|
|Expenditure|on|charitable||||||
|activities:||||||||
|In-patient|care|||3,361|789|5|4,155|
|Hospice@Home||||946|263|2|1,211|
|Bereavement<br>and family|||support|153|42||195|
|Total expenditure||||6,972|1,707|11|8690|



## 

|Support C|osts||||||||
|---|---|---|---|---|---|---|---|---|
||||HR, Health<br>fl Safety<br>and Volunteers||Finance and<br>Information|Systems|Administration|Total 2023|
|||||Kk||Kk|Kk|Kk|
|Donations|and|legacies||83||40|47|170|
|Shops||||201||97|111|409|
|Fundraising|activities|||17||8|9|34|
|In-patient|care|||388||188|213|789|
|HospiceHome||||129||63|71|263|
|Bereavement<br>family support||and||21||10||42|
|||||839||406|462|1,707|





## 

## 

|a comparative,|a comparative,|the expenditure<br>for the prior|the expenditure<br>for the prior|ye|ar is sho|wn below on|the same basis:||
|---|---|---|---|---|---|---|---|---|
|Forthe year||ended 31 March 2022|||Direct<br>Costs|Support<br>Costs|Governance<br>Costs|Total 2022|
||||||Kk|Kk|Kk|Kk|
|Costs ofraising||funds:|||||||
|Donations|and|legacies|||476|115||592|
|Shops|||||1,370|324||1,696|
|Lottery|||||192|||192|
|Fundraising|and other activities||||121|30||151|
|Investment|management||costs||81|||81|
|Expenditure|on charitable||activities:||||||
|In-patient|care||||3,090|676||3,771|
|Hospice@Home|||||912|220||1,134|
|Bereavement||and family|support||203|49||252|
|Total expenditure|||||6,445|1,414|10|7,869|
|Support Costs|||||||||
||||HR, Health|&||Finance and|||
||||Safety and|||Information|Administration|Total 2022|
||||Volunteers|||Systems|||
|||||Rk||Rk|Rk|Rk|
|Donations|and|legacies||54||30|31|115|
|Shops|||153|||85|86|324|
|Fundraising|activities|||14||8|8|30|
|In-patient|care||319|||177|180|676|
|Hospice@Home|||104|||57|59|220|
|Bereavement||and family||23||13||49|
|support|||||||||
||||667|||370|377|1,414|





## 

## 

## 

|This is stat|ed affer chargin|g:||||
|---|---|---|---|---|---|
|||||2023|2022|
|||||Rk|Rk|
|Depreciation<br>of tangible||fixed assets||186|179|
|Auditor's|remuneration:|||||
||Audit fees|||13|10|
||Non audit|services||1|13|
|Operating<br>equipment|lease rentals —land and buildings||and|195|186|
|Profit on disposal of fixed||assets||(7)||



||2023|2022|
|---|---|---|
|Wages and salaries|5,583|5,170|
|Social security costs|522|465|
|Pension costs|646|587|
||6,751|6,222|



|of employees<br>who received employ<br>in bands of f.10,000 is:|ee<br>benefits during the year|in excess o|
|---|---|---|
||2023|2022|
|260,001 - 270,000|4|2|
|270,001 —280,000|1||
|280,001 - 290,000|||
|290,001 —2100,000|||
|2110,000 - f120,000|||



## 



## 

## 

## 

## 

|cluding<br>pa|rt-time<br>a|nd bank s|taff) during t|he year were|as follows:|||
|---|---|---|---|---|---|---|---|
||||||2023||2022|
|||||Head|Full Time|Head|Full Time|
|||||Count|Equivalent|Count|Equivalent|
|Charitable|services|||134|100|128|97|
|Income generation,||including|shops|67|51|64|48|
|Support services||||26|20|24|17|
|||||227|171|216|162|



## 



## 

## 

||||Retail|Retail||Fixtures||||
|---|---|---|---|---|---|---|---|---|---|
||Freehold|Leasehold|Point <br>sale|of||Fittings|Medical|Motor||
||Property|Property|System||Plant|Equip|Equip|Vehicles|Totals|
||Kk|Kk|Kk||Rk|Kk|Kk|Kk|Kk|
|Cost:||||||||||
|At<br>1 April 2022|6,601|38||38|82|220|191|164|7,334|
|Additions||14|||9|3|—|30|56|
|Disposals||||||||(20)|(20)|
|At 31 March<br>2023|6,601|52||38|91|223|191|174|7,370|
|Depreciation||||||||||
|At<br>1 April 2022|2,230|||23|32|159|99|134|2,710|
|Charge for the|121|||8|7|18|14|16|186|
|year||||||||||
|On Disposals||||||||(10)|(10)|
|At 31 March<br>2023|2,351|35||31|39|177|113|140|2,886|
|Net Book||||||||||
|Values||||||||||
|At 31 March<br>2023|4,250|17||7|52|46|78|34|4,484|
|At 31 March<br>2022|4,371|||15|50|61|92|30|4,624|



## 

|.<br>Fixed asset investmen|ts|||
|---|---|---|---|
|||The Charity and the Group||
|Investments||2023|2022|
|||Kk|Kk|
|Market value at<br>1 April 2022||14,909|14,516|
|Additions at cost||2,728|501|
|Disposal proceeds|||(500)|
|||17,637|14,517|
|Realised and unrealised<br>investment<br>gains/(losses)||(551)|472|
|Investment<br>management|costs|(78)|(80)|
|Charges<br>within valuation||||
|Market value at 31 March|2023|17,008|14,909|





## 

## 

|Invest|ment<br>|Pro|perty|||
|---|---|---|---|---|---|
|||||2023|2022|
|||||Kk|Kk|
|Market|value|at|1 April|105|105|
|Market|value|at|31 March|105|105|



## 

|vestme|nt|in subsidiary||||
|---|---|---|---|---|---|
||||The|Charity||
||||2023||2022|
|Shares|at|cost|100||100|



## 

||||Charity||Group||
|---|---|---|---|---|---|---|
||||2023|2022|2023|2022|
||||Kk|Kk|Kk|Kk|
|Goods|for|resale|16||16|17|



|.<br>Debtors|||||
|---|---|---|---|---|
||Charity||Group||
||2023|2022|2023|2022|
||Rk|Rk|Rk|Rk|
|Trade debtors|34|26|34|27|
|Amount owed by subsidiary|33|54|||
|Other debtors|69|267|69|267|
|Prepayments|140|123|140|123|
|Accrued income|2,300|2,869|2,300|2,869|
||2,576|3,339|2,543|3,286|



|||Charity||
|---|---|---|---|
|Amounts|Owed by Subsidiary|2023|2022|
|||Kk|Kk|
|Due within one year||13|34|
|Capital|Loan|20|20|
|||33|54|





## 

## 

|.<br>Creditors: amounts<br>falling d|ue within one|year|||
|---|---|---|---|---|
||Charity||Group||
||2023|2022|2023|2022|
||Kk|Kk|Kk|Kk|
|Trade creditors|160|147|159|146|
|Taxes and social security costs|194|185|194|185|
|Other creditors|||||
|Accruals|47|52|49|55|
|Deferred Income|74|48|74|48|
||475|432|476|434|



|||At 31 <br>2022|March|Released<br>during year|D|f|d|At 31 <br>2023|March|
|---|---|---|---|---|---|---|---|---|---|
||||Rk|Rk||Rk|||Rk|
|Deferred|Income||48|(48)|||74||74|



## 

|23.<br>Analysis|of group net assets between|funds|||||||
|---|---|---|---|---|---|---|---|---|
|Fund balances <br>are represented|at 31 March 2023<br>by:|G|Unrestricted<br>eneral<br>Funds||Unrestricted<br>Designated<br>Funds||Restricted<br>Funds|Total|
|||||Kk||Kk|Kk|Kk|
|Tangible fixed|assets|||||4,484||4,484|
|Investments||||8,113||9,000||17,113|
|Current assets||||2,518|||844|3,362|
|Current<br>liabilities||||(476)||||(476)|
|Total net assets||||10,155||13,484|844|24,483|
|Fund balances <br>are represented|at 31 March 2022<br>by:|Unrestricted<br>General<br>Funds|||Unrestricted<br>Designated<br>Funds||Restricted<br>Funds|Total|
|||||Rk||Rk|Rk|Rk|
|Tangible fixed|assets|||||4,624||4,624|
|Investments||||6,014||9,000||15,014|
|Current assets||||4,806|||1,118|5,924|
|Current<br>liabilities||||(434)||||(434)|
|Total net assets||||10,386||13,624|1,118|25,128|





## 

## 

## 

## 

||||2023|2022|2023|2022|
|---|---|---|---|---|---|---|
||||Land L<br>Buildings|Land &<br>Buildings|Other|Other|
|Due|within one year||140|183|||
|Due|between|two and five years|190|205|||
|Due|after 5years||||||
||||334|388|||



## 



## 

## 

||||2023|2022|
|---|---|---|---|---|
||||Rk|Rk|
|Net movement<br>in funds|||(94)|3,075|
|Adjustments<br>for:|||||
|Dividends<br>interest and rents from||investments|(391)|(407)|
|Depreciation<br>charges|||186|179|
|Profit on sale of fixed assets|||(7)||
|Investment<br>management|charges||78|80|
|Decrease<br>in stocks|||1|2|
|Decrease/(Increase)<br>in|debtors||819|(1,415)|
|Increase<br>in creditors|||42|43|
|Net cash provided<br>by operating||activities|634|1,557|



## 

|alysis|ofc|hange|s<br>in net funds||||
|---|---|---|---|---|---|---|
|||||At 31||At 31|
|||||March|Cash flow|March|
|||||2022||2023|
|||||Kk|Kk|Kk|
|Cash|and|cash|equivalents|2,621|(1,818)|803|





## 

## 

|Consolidated<br>Statement<br>of|Financial Activities (Including|Financial Activities (Including|Financial Activities (Including|Income and Expenditure|Account)||
|---|---|---|---|---|---|---|
|for the year ending<br>31 March||2022|||||
|||||Unrestricted|Restricted|Total Funds|
|||||Funds|Funds|2022|
|||||||Ek|
|Income from:|||||||
|Donations<br>and legacies||||3,432|1,721|5,153|
|Income from charitable|activities:||||||
|Grants and contract income||||2,083|392|2,475|
|Income from other trading||activities:|||||
|Shops||||2,128||2,128|
|Lottery||||387||387|
|Fundraising<br>activities||||394||394|
|Investment<br>Income||||407||407|
|Total income||||8,831|2,113|10,944|
|Expenditure<br>on:|||||||
|Costs ofraising funds:|||||||
|Donations<br>and legacies||||592||592|
|Shops||||1,696||1,696|
|Lottery||||192||192|
|Fundraising<br>activities||||151||151|
|Investment<br>Management||Costs||81||81|
|Expenditure<br>on charitable||activities:|||||
|In-patient<br>Care||||3,051|720|3,771|
|Sunflower Centre|||||||
|Hospice@Home||||749|385|1,134|
|Lymphoedema<br>Service|||||||
|Bereavement<br>and Family Support||||252||252|
|Total expenditure||||6,764|1,105|7,869|
|Net income before other|recognised||gains|2,067|1,008|3,075|
|Realised and unrealised|gains on investments|||472||472|
|Net income||||2,539|1,008|3,547|
|Total funds brought<br>forward||||21,471|110|21,581|
|Total funds carried forward||||24,010|1,118|25,128|



